Compare Stocks: MLEC vs. APVO vs. ERNA vs. JAGX
Compare normalized stock price performance over 6 months, 1 year or 2 years. Each line starts at 0%, so different stock prices can be compared on the same scale.
MLECAPVOERNAJAGX
Market Snapshot
Current market context for the selected companies.
MLEC
$7.00
Market Cap
$5.08M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-21
APVO
$2.68
Market Cap
$4.83M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-21
ERNA
$4.86
Market Cap
$5.67M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-21
JAGX
$0.87
Market Cap
$4.26M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-21
Performance
Absolute returns and relative performance versus SPY.
| Metric | MLEC | APVO | ERNA | JAGX |
|---|---|---|---|---|
| 1 Month | -2.5% | -38.7% | +21.8% | -15.8% |
| 1 Month vs SPY | -6.2% | -42.4% | +18.1% | -19.5% |
| 3 Months | -4.9% | -46.8% | -61.0% | -75.0% |
| 3 Months vs SPY | -8.0% | -49.9% | -64.1% | -78.1% |
| 6 Months | -57.4% | -59.8% | -37.3% | -95.9% |
| 6 Months vs SPY | -68.4% | -70.8% | -48.4% | -107.0% |
| 1 Year | -80.5% | -92.4% | -87.5% | -98.7% |
| 1 Year vs SPY | -100.5% | -112.4% | -107.5% | -118.7% |
| 2 Years | -94.7% | -100.0% | -99.2% | -99.9% |
| 2 Years vs SPY | -132.8% | -138.1% | -137.4% | -138.1% |
Growth & Profitability
Operating growth, margins and capital efficiency.
Valuation
Common valuation multiples shown side by side.
Cash Flow & Balance Sheet
Cash generation and leverage context.
Earnings Outlook
Upcoming earnings expectations when available.